C07K 19 - Hybrid peptides - Patents Sitemap

Patents for C07K 19 - Hybrid peptides (29,428)
11/2004
11/04/2004	US20040219640 Polypeptides homologous to VEGFand BMPI
11/04/2004	US20040219632 T1r3 a novel taste receptor
11/04/2004	CA2526914A1 Compositions and methods relating to stop-1
11/04/2004	CA2523197A1 Peptide vectors
11/04/2004	CA2520097A1 Truncated baff receptors
11/03/2004	EP1472353A2 Group b streptococcus antigen
11/03/2004	EP1472351A2 Amino acid sequences capable of facilitating penetration across a biological barrier
11/03/2004	EP1472273A2 Compositions and methods for the treatement of immune related diseases
11/03/2004	EP1472238A1 Bioluminescent protease assay
11/03/2004	EP1471933A1 Albumin-fused anti-angiogenesis peptides
11/03/2004	EP1471928A1 Hiv inhibiting proteins
11/03/2004	EP0698101B1 Hepatitis-c virus type 4, 5 and 6
11/03/2004	EP0594843B1 Antibody assay for amylin
11/03/2004	CN1543505A Novel amylases and uses thereof
11/03/2004	CN1543504A 疫苗 Vaccine
11/03/2004	CN1543474A T1R taste receptors and genes encoding same
11/03/2004	CN1542019A Anti human non-Hodgkin's lymphoma chimeric antibody and its derivative and application
11/03/2004	CN1173735C Use of anti-gp 39 antibodies for treatment and/or reversal of lupus and associated kidney disease
11/02/2004	US6811782 Peptide composition as immunogen for the treatment of allergy
11/02/2004	CA1341463C Cyclosporin a derivatives modified at position 1 and fluorescence polarization assay for cyclosporin a and metabolites
10/2004
10/28/2004	WO2004092215A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
10/28/2004	WO2004018660A3 Novel lipases and uses thereof
10/28/2004	WO2004005477A3 Protein microarrays on mirrored surfaces for performing proteomic analyses
10/28/2004	WO2003064609A3 Targeted immunogens
10/28/2004	WO2001098460A3 Fusion proteins of mycobacterium tuberculosis
10/28/2004	US20040216180 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
10/28/2004	US20040215008 Production of proteins by autoproteolytic cleavage
10/28/2004	US20040214996 Multimeric peptides/immunoglobulins for use in the treatment of bone disorders
10/28/2004	US20040214245 Diagnostic and therapeutic use of antibodies against the urokinase receptor
10/28/2004	US20040214229 Amino acid sequences for use in diagnosis, prevention and treatment of sepsis and infections
10/28/2004	US20040214165 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
10/28/2004	US20040213807 Use of Parapox B2L protein to modify immune responses to administered antigens
10/28/2004	US20040213790 VEGF-related protein
10/28/2004	CA2521809A1 Improved heat shock protein-based vaccines and immunotherapies
10/27/2004	EP1471142A1 Heterodimeric receptor libraries using phagemids
10/27/2004	EP1470420A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
10/27/2004	EP1470237A2 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
10/27/2004	EP1470229A1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state
10/27/2004	EP1470158A2 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof
10/27/2004	EP1469883A2 Compositions and methods for regulating lymphocyte activation
10/27/2004	CN1541271A Methods for large scale prodn. of recombinant DNA-derived tPA or K2S molecules
10/27/2004	CN1541266A FCE fusion proteins for treatment of allergy and asthma
10/27/2004	CN1541263A Improved methods for binding AcmA-type protein anchor fusions to cell-wall material of micro-organisms
10/27/2004	CN1541226A Antibodes specific for CD44V6
10/27/2004	CN1541107A Growth factor complex
10/27/2004	CN1539850A Recombined protein of anti tumour, encoded gene and application
10/27/2004	CN1173037C Single-chain bifunctional glycoprotein hormones
10/26/2004	US6809185 Created by heterodimerization of immunoglobulin domains; have two or more antigen binding parts; for diagnosis/treatment of human diseases
10/26/2004	US6809180 Compositions and methods for screening antimicrobials
10/26/2004	US6808902 Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
10/26/2004	CA2142973C A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes gp 130
10/26/2004	CA1341461C T helper cell growth factor
10/21/2004	WO2004032832A3 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment
10/21/2004	WO2003026490A3 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules
10/21/2004	WO2003024392A3 Compositions and methods for the diagnosis and treatment of tumor
10/21/2004	US20040209313 T2R receptor binding assays that identify potential bitter taste modulatory compounds
10/21/2004	US20040209286 Comprises nucleotide sequences coding g protein coupled receptors for use in identifying modulators of sweet taste transduction; food processing; improving palatability of low-calorie beverages through the development of new artificial sweeteners
10/21/2004	US20040209264 Comprises nucleotide sequences coding daugther of legless protein for use in identifying modulator for tissue regeneration and repair and the treatment of blood disorders
10/21/2004	US20040208889 Pharmaceutical use for secreted bacterial effector proteins
10/21/2004	CA2521402A1 Pectate lyases, nucleic acids encoding them and methods for making and using them
10/20/2004	EP1468284A2 Method for measuring intracellular atp and/or gene expression
10/20/2004	EP1468020A2 Multimers of receptor-binding ligands
10/20/2004	EP1468017A1 A complex of a human foxc2 protein and a foxc2-interacting protein
10/20/2004	EP1468014A2 Compositions and methods for wt1 specific immunotherapy
10/20/2004	EP1468012A1 Biomolecule transduction motif mph-1-btm and the use thereof
10/20/2004	EP1468011A1 Biomolecule transduction motif sim-2-btm and the use thereof
10/20/2004	EP0722461B1 Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
10/20/2004	CN1538176A Antagonism agent and ultra-antagonism agent for hormone screened by membrane molecule gp 130 active cell physiological regulation mechanism
10/20/2004	CN1537866A Heteroprotein of melanoma epi (Mage-1, HLA-Al) and bacteriophage coat protein and its application
10/20/2004	CN1171997C Modified TLE-2-receptor ligands
10/19/2004	US6806079 Methods for producing members of specific binding pairs
10/14/2004	WO2004087767A1 Polypeptide
10/14/2004	WO2004031243A9 Protein polymer and process for producing the same
10/14/2004	WO2004024063A3 Compositions and methods for the diagnosis and treatment of tumor
10/14/2004	WO2003104282A3 Glycoprotein vi - fc fusion protein for treating vascular disorders
10/14/2004	WO2003089620A3 Phospholipases, nucleic acids encoding them and methods for making and using them
10/14/2004	US20040204568 Comprises nucleotide sequences coding cell adhesion molecules for use in the diagnosis, prevention and treatment of autoimmune and cell proliferative disorders
10/14/2004	US20040204565 Use of multivalent chimeric peptide-loaded, MHC/IG molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses
10/14/2004	US20040204364 Peptides for activation and inhibition of deltaPKC
10/14/2004	US20040203128 Use of PP2A phosphatase modulators in the treatment of mental disorders
10/14/2004	US20040203099 Conjugate of a transport protein and a protein for modulation of notch signalling
10/14/2004	US20040203039 Attenuated salmonella SP12 mutants as antigen carriers
10/14/2004	US20040202679 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein.
10/14/2004	US20040202662 Humanised antibodies
10/14/2004	US20040202646 Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy
10/14/2004	CA2734606A1 Polypeptide comprising cell adhesion motif, t cell epitope and b cell epitope for inducing antibody production
10/13/2004	EP1466624A1 Drug for regenerating tissue and vessel and method therefor
10/13/2004	EP1465999A2 Fusion proteins
10/13/2004	EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy
10/13/2004	EP1465912A2 Novel chimeric tnf ligands
10/12/2004	US6803453 Using antibodies directed to a novel class or family of transforming growth factor (tgf)-beta binding proteins; for diagnosis, prevention, treatment of osteoporosis
10/12/2004	US6803211 Cancer therapy
10/12/2004	US6803039 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM
10/07/2004	WO2004085479A2 Treatment of viral infections
10/07/2004	WO2004085478A2 Improved fc fusion proteins
10/07/2004	WO2004084942A2 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18)
10/07/2004	WO2004040262A8 Compositions and methods for modifying toxic effects of proteinaceous compounds
10/07/2004	WO2003070981A8 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines
10/07/2004	WO2003057725A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
10/07/2004	WO2002088317A3 Fusion molecules and methods for treatment of immune diseases

1 ... 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 ... 295